Blog
Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine
As of July 12, the number of new cases of COVID-19 in the U.S. has surpassed 60,000 for the fifth day in a row. Unfortunately, this rise cannot be attributed to increases in testing. For most of
Why 1Life Healthcare Stock Surged Last Week
Shares of 1Life Healthcare (NASDAQ: ONEM) rose more than 14% last week, and the stock is up more than 124% over the past three months after closing at $41.60 on Friday.
The membership-based
Why Is Everyone Talking About Livongo Health Stock?
About 147 million Americans are currently suffering from chronic health conditions, and over 40% have more than one. Currently, patients in this category account for more than 90% of the U.S.
Is Energy Transfer Stock a Buy?
Energy Transfer (NYSE: ET) stock is surely the worst-hit stock among its top MLP peers. Since October 2018 -- when Energy Transfer Equity and Energy Transfer Partners were merged to form the current
Is First Solar Stock a Buy?
The solar industry continues to grow around the world, yet solar companies continue to struggle to make consistent profits. This year, just as there seemed to be some stability in the industry, new
Will a Second COVID-19 Relief Bill Make Medicare More Accessible to Seniors in Need?
Having the right health coverage in place is important at all times. During a pandemic, it's an absolute necessity. And that's why lawmakers are advocating to make Medicare more accessible at a time
5 Awful Stocks Robinhood Investors Are Buying
No matter how long you've been an investor, there's simply nothing that could have prepared you for what 2020 has offered thus far. In a roughly four-month span, investors have dealt with about a
Is Intellia Therapeutics Stock a Buy?
Intellia Therapeutics (NASDAQ: NTLA) is a biotech company that focuses on gene editing, a relatively new technology that could allow scientists to devise therapies for otherwise impossible-to-treat
Why Big Pharma's $1 Billion Bet to Prevent a Bacterial Pandemic Matters for You
Some might think of big pharmaceutical companies as cutthroat corporations only interested in their own profits and self-preservation. But what if told you that several big pharma companies are
2 Numbers I'm Watching at Annaly Capital Management Due July 15
The mortgage real estate investment trust (REIT) sector has been a tough place to be over the past several months. A massive tightening of credit due to COVID-19 fears lopped sizable chunks out of
Is PNC Financial Services a Buy?
Banks are hit-or-miss investments right now, due to the state of the economy. But one bank you might want to take a swing at is PNC Financial Services (NYSE: PNC).
The nation's seventh-largest bank
Disney+ to Premiere "Clone Wars" Spinoff in 2021
Mission Impossible 7. Wonder Woman 1984. Stranger Things 4. The season 10 finale of The Walking Dead. These are just a handful of the motion pictures and television shows that have been delayed
Here's Gilead Sciences' Great COVID-19 Opportunity That You'll Really Want to Watch
Plenty of drugmakers are developing potential treatments for COVID-19. But -- so far, at least -- only Gilead Sciences (NASDAQ: GILD) can claim a COVID-19 therapy that has sailed through late-stage
Are There Warning Signs About Moderna's COVID-19 Vaccine Program?
In any discussion about the race to develop a vaccine against the novel coronavirus that causes COVID-19, Moderna (NASDAQ: MRNA) will almost certainly be mentioned. The biotech ranked among a select
Goldman Sachs Says This Simple Measure Can Save Lives and the Economy
As we all know, the fate of many lives, not to mention the U.S. and global economy, largely depends on the containment of the novel COVID-19 coronavirus. While there are many vaccine candidates
Is Ovid Therapeutics Stock a Buy?
Shares of Ovid Therapeutics (NASDAQ: OVID) have more than doubled over the past four months, a performance the clinical-stage biotech company owes in part to a positive rating from an analyst. In
2 Top Stocks to Buy in July
America is in a recession, but that doesn't make this is a bad time to invest. Recessions can be the best time to buy stocks because you can pick up quality companies at affordable prices.
Here are
Earnings: 3 Hot Stocks to Watch This Month
This has been a wild year for investors. While most stocks fell sharply in February and March during the coronavirus market crash, many have already recovered. Even more, some stocks have soared to
Do You Need An Air Purifier?
An air purifier is an electronic device that captures pollutants, irritants, and other particles in the air, and delivers fresh air into the room where it's used. The Environmental Protection Agency
Buffett Has Gained $108 Billion on These 5 Stocks
In recent years, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett has taken a lot of criticism for underperforming the benchmark S&P 500. Some folks have even implied that the Oracle
2 Simple Reasons Why Surging COVID-19 Cases Are Terrible for Social Security
If you've been paying any attention to the news, you're no doubt aware that, despite hopes that the coronavirus pandemic in the U.S. would be brought under control by the summer, things only seem
A Big Change Is Coming to the Next Stimulus Deal
There's little question that 2020 has tested the resolve of Americans more so than any year before it. The coronavirus disease 2019 (COVID-19) pandemic has exacted an incredible physical and
Abbott Laboratories and Edwards Lifesciences Settle Patent Fight
Abbott Laboratories (NYSE: ABT) and Edwards Lifesciences (NYSE: EW) are burying the hatchet. The two healthcare companies announced in separate press releases that they have reached a settlement on
Why Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Sank Today
Cruise ship stocks fell on Monday after surging COVID-19 case counts forced government officials in California to reverse some of the state's economic reopening plans.
By the close of trading
Is Tesla Stock a Buy Right Now?
Tesla (NASDAQ: TSLA) is among 2020's hottest stocks. As of market close on Monday, the electric-car maker's shares are up more than 250% year to date. Meanwhile, the S&P 500 is down 2%. The stock's


